Skip to Main Content

Author Details

Gyorgy Petrovics
Henry Jackson Foundation for the Advancement of Military Medicine (HJF)
1990
100
37
PMIDPaper TitleJournal TitlePublished Year
36768533Biomarkers of Aggressive Prostate Cancer at Diagnosis.Int J Mol Sci2023
37945903Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.Nat Genet2023
36768533Biomarkers of Aggressive Prostate Cancer at Diagnosis.Int J Mol Sci2023
37196930Development and characterization of an ETV1 rabbit monoclonal antibody for the immunohistochemical detection of ETV1 expression in cancer tissue specimens.J Immunol Methods2023
36872133Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.Eur Urol2023
36479985Differentially expressed glycoproteins in pre- and post-digital rectal examination urine samples for detecting aggressive prostate cancer.Proteomics2023
37311464Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.Am J Hum Genet2023
37239075Association of <i>TP53</i> Single Nucleotide Polymorphisms with Prostate Cancer in a Racially Diverse Cohort of Men.Biomedicines2023
37292833Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry.medRxiv2023
37945903Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.Nat Genet2023
37292833Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry.medRxiv2023
37311464Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.Am J Hum Genet2023
37239075Association of <i>TP53</i> Single Nucleotide Polymorphisms with Prostate Cancer in a Racially Diverse Cohort of Men.Biomedicines2023
37196930Development and characterization of an ETV1 rabbit monoclonal antibody for the immunohistochemical detection of ETV1 expression in cancer tissue specimens.J Immunol Methods2023
36479985Differentially expressed glycoproteins in pre- and post-digital rectal examination urine samples for detecting aggressive prostate cancer.Proteomics2023
36872133Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.Eur Urol2023
34127801Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24.Prostate Cancer Prostatic Dis2022
35354846Focal p53 protein expression and lymphovascular invasion in primary prostate tumors predict metastatic progression.Sci Rep2022
34127801Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24.Prostate Cancer Prostatic Dis2022
35292633Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes.Nat Commun2022
35031163A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.Eur Urol2022
35152271Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score.Prostate Cancer Prostatic Dis2022
35354846Focal p53 protein expression and lymphovascular invasion in primary prostate tumors predict metastatic progression.Sci Rep2022
35152271Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score.Prostate Cancer Prostatic Dis2022
35031163A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.Eur Urol2022
35292633Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes.Nat Commun2022
32930425African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer.Int J Cancer2021
33473200Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.Nat Genet2021
32930425African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer.Int J Cancer2021
32967771Prognostic features of Annexin A2 expression in prostate cancer.Pathology2021
33398198Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.Nat Genet2021
33398198Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.Nat Genet2021
33473200Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.Nat Genet2021
32967771Prognostic features of Annexin A2 expression in prostate cancer.Pathology2021
32341752Association of germline genetic variants with <i>TMPRSS2-ERG</i> fusion status in prostate cancer.Oncotarget2020
32429558Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression.Cancers (Basel)2020
31910880Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer.J Transl Med2020
32409115A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry.Eur Urol2020
32341752Association of germline genetic variants with <i>TMPRSS2-ERG</i> fusion status in prostate cancer.Oncotarget2020
31910880Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer.J Transl Med2020
32409115A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry.Eur Urol2020
32429558Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression.Cancers (Basel)2020
30542053Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population.Prostate Cancer Prostatic Dis2019
31741711Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies <i>ERG</i> as the strongest independent predictor of recurrence.Oncotarget2019
31842254Analysis of <i>PMEPA1</i> Isoforms (<i>a</i> and <i>b</i>) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer.Cancers (Basel)2019
30542053Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population.Prostate Cancer Prostatic Dis2019
31013716A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges.Int J Mol Sci2019
31842254Analysis of <i>PMEPA1</i> Isoforms (<i>a</i> and <i>b</i>) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer.Cancers (Basel)2019
31741711Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies <i>ERG</i> as the strongest independent predictor of recurrence.Oncotarget2019
31013716A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges.Int J Mol Sci2019
  • 1 - 50 of 200

Recommended Authors

Julie Livingstone
University of California los angeles
Career Start Year 2011
Number of shared co-authors 22
Adam G Sowalsky
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 8
Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 21
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 5
Tamara L Lotan
Johns Hopkins University School of Medicine
Career Start Year 2006
Number of shared co-authors 23
Christina M??ller-Koop
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 2006
Number of shared co-authors 2
Robert H Bell
University of British Columbia
Career Start Year 2004
Number of shared co-authors 5
Charlie E Massie
University of Cambridge
Career Start Year 2003
Number of shared co-authors 14
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 26
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 16
Ladan Fazli
University of British Columbia
Career Start Year 2002
Number of shared co-authors 21
Luke A Selth
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 5
David S Rickman
Meyer Cancer Center
Career Start Year 2001
Number of shared co-authors 6
Ilsa Coleman
Fred Hutchinson Cancer Center
Career Start Year 2001
Number of shared co-authors 16
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 3
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 9
Yuzhuo Wang
University of British Columbia
Career Start Year 2000
Number of shared co-authors 13
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 12
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 7
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 13
Claudia Hube-Magg
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1997
Number of shared co-authors 2
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 39
Rosina T Lis
National Cancer Institute
Career Start Year 1992
Number of shared co-authors 17
Mark A Rubin
University of Bern
Career Start Year 1990
Number of shared co-authors 45
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 13
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 26
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 3
Tapio Visakorpi
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 1987
Number of shared co-authors 46
George Steven Bova
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 1982
Number of shared co-authors 21
Francesca Demichelis
University of Trento
Career Start Year 1969
Number of shared co-authors 14

Collaborators

Shiv Srivastava
Co-authored papers 71
David G McLeod
Co-authored papers 41
Yongmei Chen
Co-authored papers 29
Robin J Leach
University of Texas Health San Antonio
Co-authored papers 12
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers 12
Dana C Crawford
Cleveland Institute for Computational Biology, Case Western Reserve University
Co-authored papers 11
Janet L Stanford
Fred Hutchinson Cancer Research Center
Co-authored papers 10
Sonja I Berndt
Co-authored papers 10
William J Blot
Vanderbilt University Medical Center
Co-authored papers 10
Sue A Ingles
Co-authored papers 10
Esther M John
Co-authored papers 10
Christopher A Haiman
University of Southern California
Co-authored papers 10
Chad D Huff
University of Texas M.D. Anderson Cancer Center
Co-authored papers 9
Ian M Thompson
CHRISTUS Santa Rosa Hospital-Medical Center
Co-authored papers 9
William B Isaacs
The Brady Urological Institute, The Johns Hopkins School of Medicine
Co-authored papers 9
David V Conti
Co-authored papers 9
William S Bush
Cleveland Institute for Computational Biology, Case Western Reserve University
Co-authored papers 9
Rick A Kittles
Morehouse School of Medicine
Co-authored papers 9
John D Carpten
Co-authored papers 9
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 9
Jeannette T Bensen
Co-authored papers 9
Sudhir Srivastava
National Cancer Institute
Co-authored papers 8
Jianfeng Xu
Co-authored papers 8
Douglas F Easton
University of Cambridge
Co-authored papers 8
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 8
Burcu F Darst
Fred Hutchinson Cancer Center
Co-authored papers 8
Stephen K Van Den Eeden
Kaiser Permanente Northern California, University of California san francisco
Co-authored papers 7
Eric A Klein
Cleveland Clinic
Co-authored papers 7
Lorelei A Mucci
Co-authored papers 7
Kathryn L Penney
Co-authored papers 7
Release 1.2